FEBS Letters
Volume 578, Issue 1 , Pages 135-139 , 3 December 2004

Reduction of mitochondrial tRNALeu(UUR) aminoacylation by some MELAS-associated mutations

Edited by Horst Feldmann

  • Rui Hao

      Affiliations

    • State Key Laboratory of Molecular Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, The Chinese Academy of Sciences, PR China
    • Graduate School of the Chinese Academy of Sciences, 320 Yue Yang Road, Shanghai 200031, PR China
    • ,
  • Yong-Neng Yao

      Affiliations

    • State Key Laboratory of Molecular Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, The Chinese Academy of Sciences, PR China
    • ,
  • Yong-Gang Zheng

      Affiliations

    • State Key Laboratory of Molecular Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, The Chinese Academy of Sciences, PR China
    • ,
  • Min-Gang Xu

      Affiliations

    • State Key Laboratory of Molecular Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, The Chinese Academy of Sciences, PR China
    • ,
  • En-Duo Wang

      Affiliations

    • State Key Laboratory of Molecular Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, The Chinese Academy of Sciences, PR China
    • Corresponding Author InformationCorresponding author. Fax: +86 21 54921011

Received 1 October 2004 ,Revised 30 October 2004 ,Accepted 3 November 2004.

References 

  1. Söll D. The accuracy of aminoacylation – ensuring the fidelity of the genetic code. Experientia. 1990;46:1089–1096
  2. Helm M, Brule H, Friede D, Giegé R, Putz D, Florentz C. Search for characteristic structural features of mammalian mitochondrial tRNAs. RNA. 2000;6:1356–1379
  3. Wittenhagen LM, Kelley SO. Impact of disease-related mitochondrial mutations on tRNA structure and function. Trends Biochem. Sci. 2003;28:605–611
  4. Piechota J, Mroczek K, Bartnik E. MELAS as an example of a mitochondrial disease. J. Appl. Genet. 2001;42:351–358
  5. Goto Y, Nonaka I, Horai S. A mutation in the tRNALeu(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature. 1990;348:651–653
  6. Morten KJ, Cooper JM, Brown GK, Lake BD, Pike D, Poulton J. A new point mutation associated with mitochondrial encephalomyopathy. Hum. Mol. Genet. 1993;2:2081–2087
  7. Sato W, Hayasaka K, Shoji Y, Takahashi T, Takada G, Saito M, et al. A mitochondrial tRNALeu(UUR) mutation at 3,256 associated with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS). Biochem. Mol. Biol. Int. 1994;33:1055–1061
  8. Goto Y, Nonaka I, Horai S. A new mtDNA mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS). Biochim. Biophys. Acta. 1991;1097:238–240
  9. Goto Y, Tsugane K, Tanabe Y, Nnaka I, Horai S. A new point mutation at nucleotide pair 3291 of the mitochondrial tRNALeu(UUR) gene in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS). Biochem. Biophys. Res. Commun. 1994;202:1624–1630
  10. Chomyn A, Enriquez JA, Micol V, Fernandez-Silva P, Attardi G. The mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episode syndrome-associated human mitochondrial tRNALeu(UUR) mutation causes aminoacylation deficiency and concomitant reduced association of mRNA with ribosomes. J. Biol. Chem. 2000;275:19198–19209
  11. Park H, Davidson E, King MP. The pathogenic A3243G mutation in human mitochondrial tRNALeu(UUR) decreases the efficiency of aminoacylation. Biochemistry. 2003;42:958–964
  12. Sohm B, Frugier M, Brule H, Olszak K, Przykorska A, Florentz C. Towards understanding human mitochondrial leucine aminoacylation identity. J. Mol. Biol. 2003;328:995–1010
  13. Yao YN, Wang L, Wu XF, Wang ED. The processing of human mitochondrial leucyl-tRNA synthetase in the insect cells. FEBS Lett. 2003;534:139–142
  14. Yao YN, Wang L, Wu XF, Wang ED. Human mitochondrial leucyl-tRNA synthetase with high activity produced from Escherichia coli. Protein Expr. Purif. 2003;30:112–116
  15. Enriquez JA, Cabzas-Herrera J, Bayona-Bafaluy MP, Attardi G. Very rare complementation between mitochondria carrying different mitochondrial DNA mutations points to intrinsic genetic autonomy of the organelles in cultured human cells. J. Biol. Chem. 2000;275:11207–11215
  16. Takai D, Isobe K, Hayashi J. Transcomplementation between different types of respiration-deficient mitochondria with different pathogenic mutant mitochondrial DNAs. J. Biol. Chem. 1999;274:11199–11202
  17. Li Y, Wang ED, Wang YL. A modified procedure for fast purification of T7 RNA polymerase. Protein Expr. Purif. 1999;16:355–358
  18. Fechter P, Rudinger J, Giegé R, Theobald-Dietrich A. Ribozyme processed tRNA transcripts with unfriendly internal promoter for T7 RNA polymerase: production and activity. FEBS Lett. 1998;436:99–103
  19. Puglisi JD, Tinoco I. Absorbance melting curves of RNA. Methods Enzymol. 1989;180:304–325
  20. Heddi A, Stepien G, Benke PJ, Wallace DC. Coordinate induction of energy gene expression in tissues of mitochondrial disease patients. J. Biol. Chem. 1999;274:22968–22976
  21. Levinger L, Oestreich I, Florentz C, Morl M. A pathogenesis-associated mutation in human mitochondrial tRNALeu(UUR) leads to reduced 3′-end processing and CCA addition. J. Mol. Biol. 2004;337:535–544
  22. Helm M, Brule H, Degoul F, Cepanec C, Leroux JP, Giege R, et al. The presence of modified nucleotides is required for cloverleaf folding of a human mitochondrial tRNA. Nucleic Acids Res. 1998;26:1636–1643
  23. Sohm B, Sissler M, Park H, King MP, Florentz C. Recognition of human mitochondrial tRNALeu(UUR) by its cognate leucyl-tRNA synthetase. J. Mol. Biol. 2004;339:17–29
  24. Kelley SO, Steinberg SV, Schimmel P. Functional defects of pathogenic human mitochondrial tRNAs related to structural fragility. Nat. Struct. Biol. 2000;7:862–865
  25. Kelley SO, Steinberg SV, Schimmel P. Fragile T-stem in disease-associated human mitochondrial tRNA sensitizes structure to local and distant mutations. J. Biol. Chem. 2001;276:10607–10611
  26. Sissler M, Helm M, Frugier M, Giege R, Florentz C. Aminoacylation properties of pathology-related human mitochondrial tRNALys variants. RNA. 2004;10:841–853
  27. Wittenhagen LM, Kelley SO. Dimerization of a pathogenic human mitochondrial tRNA. Nat. Struct. Biol. 2002;9:586–590
  28. Feuermann M, Francisci S, Rinaldi T, De Luca C, Rohou H, Frontali L, et al. The yeast counterparts of human ‘MELAS’ mutations cause mitochondrial dysfunction that can be rescued by overexpression of the mitochondrial translation factor EF-Tu. EMBO Rep. 2003;4:53–58
  29. Quigley GJ, Rich A. Structural domains of transfer RNA molecules. Science. 1976;194:796–806
  30. Uziel G, Carrara F, Granata T, Lamantea E, Mora M, Zeviani M. Neuromuscular syndrome associated with the 3291T→C mutation of mitochondrial DNA: a second case. Neuromuscul. Disord. 2000;10:415–418

PII: S0014-5793(04)01354-7

doi: 10.1016/j.febslet.2004.11.004

FEBS Letters
Volume 578, Issue 1 , Pages 135-139 , 3 December 2004